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Abstract
Background: Caffeine supplementation (CAFF) has an established ergogenic effect on physical performance and
the psychological response to exercise. However, few studies have compared the response to CAFF intake among
athletes of different competition level. This study compares the acute effects of CAFF on anaerobic performance,
mood and perceived effort in elite and moderately-trained recreational athletes.
Methods: Participants for this randomized, controlled, crossover study were 8 elite athletes (in the senior boxing
national team) and 10 trained-recreational athletes. Under two experimental conditions, CAFF supplementation
(6 mg/kg) or placebo (PLAC), the athletes completed a Wingate test. Subjective exertion during the test was
recorded as the rating of perceived exertion (RPE) both at the general level (RPEgeneral) and at the levels
muscular (RPEmuscular) and cardiorespiratory (RPEcardio). Before the Wingate test, participants completed the
questionnaires Profiles of Moods States (POMS) and Subjective Vitality Scale (SVS).
Results: In response to CAFF intake, improvements were noted in Wpeak (11.22 ± 0.65 vs 10.70 ± 0.84; p =
0.003; η2p =0.44), Wavg (8.75 ± 0.55 vs 8.41 0.46; p = 0.001; η
2
p =0.53) and time taken to reach Wpeak (7.56 ± 1.58
vs 9.11 ± 1.53; p < 0.001; η2p =0.57) both in the elite and trained-recreational athletes. However, only the elite
athletes showed significant increases in tension (+ 325%), vigor (+ 31%) and SVS (+ 28%) scores after the
intake of CAFF compared to levels recorded under the condition PLAC (p < 0.05). Similarly, levels of vigor
after consuming CAFF were significantly higher in the elite than the trained-recreational athletes (+ 5.8%).
Conclusions: CAFF supplementation improved anaerobic performance in both the elite and recreational
athletes. However, the ergogenic effect of CAFF on several mood dimensions and subjective vitality was
greater in the elite athletes.
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Background
Caffeine (CAFF) is a nutritional supplement with a high
level of scientific evidence supporting its effect of im-
proving sports performance [1]. This explains why CAFF
has become one of the most widely consumed nutri-
tional aids among athletes [2, 3], both professional [4, 5]
and recreational/amateur [6, 7]. Moreover, its popularity
has also increased since it was removed from the list of
banned substances for sports in 2004 [8].
As CAFF is molecularly similar to adenosine, it blocks
adenosine receptors A1, A2a and A2b [9], acting as a
powerful central nervous system stimulator [10], and up-
regulating the synthesis of catecholamines with neuro-
transmitter activity (e.g., dopamine, epinephrine and
norepinephrine) [11, 12]. As skeletal muscle has many
adenosine receptors [13], CAFF intake increases neuro-
muscular recruitment [14, 15]. Further, at the muscle
tissue level, CAFF increases the frequency of calcium
channel opening [16], promoting the release of calcium
into the myoplasm and thus enhancing muscle contrac-
tion [17]. These effects make CAFF an effective ergo-
genic aid in various exercise actions such as endurance
sports [18], exercise efforts with high glycolytic demands
[19], resistance exercise [20], and racket [21], combat
[22] and team sports [23].
Besides increasing catecholamine levels, the effects of
CAFF supplementation on the central nervous system
include increased sympathetic activity and reduced para-
sympathetic activity. In turn, these effects modify a per-
son’s mood [24, 25], enhancing alertness and reducing
the feeling of fatigue [26, 27], such that there is a sub-
jective perception of vitality when faced with a physical
activity task. Increased perceived tension reflects
optimization of the state of preparation of an athlete to
undertake a physical test. The relationship between sub-
jective tension and an athlete’s preparation state follows
a hump-shaped function, whereby levels of tension that
are too low or too high will mean a decline in perform-
ance when adjusting to a person’s optimal performance
zone [28]. This explains the known effects of CAFF on
emotional factors of tension and vigor, increasing their
perceived levels and improving an individual’s willing-
ness to tackle the task at hand [29, 30]. In turn, this re-
duces perceived effort levels (RPE), both in trained and
untrained individuals [31].
With the objective of testing whether CAFF consump-
tion is conditioned by an athlete’s training level, Skinner
et al. compared blood caffeine concentrations after tak-
ing an oral CAFF supplement in untrained subjects ver-
sus trained resistance sport athletes [32]. Results
indicated that caffeine concentrations were higher in the
trained athletes. This suggests that the ergogenic effect
of CAFF supplementation could be associated with the
training level (trained vs. untrained), and performance
level (elite vs. recreational) of the athlete. Evidence sup-
porting this theory is, however, scarce and results have
been conflicting [13, 33–37]. Hence, while various stud-
ies have examined populations of athletes with different
performance levels, so far no study has tried to assess
whether an athlete’s training level could determine the
ergogenic effects of CAFF supplementation. The present
study was therefore designed to compare the acute effects
of CAFF supplementation on physical performance and
mood when executing anaerobic efforts and to assess the




Eighteen men were enrolled. Eight of these partici-
pants were elite athletes (age: 22.0 ± 1.8 years; body
mass: 65.6 ± 10.8 kg; height: 1.69 ± 0.09 m; BMI: 22.7 ±
1.3 kg/m2), members of the Spanish national senior
male boxing team who had been training at the High
Performance Center in Madrid, Spain, and participating in
international competitions for over 2 years. The remaining
10 subjects were undergraduate students from the Depart-
ment of Sport Sciences of the Universidad de Alfonso X El
Sabio, Madrid, Spain (age: 22.5 ± 1.8 years; body mass:
75.0 ± 10.8 kg; height: 1.75 ± 0.04m; BMI: 24.3 ± 2.6 kg/m2).
These subjects were categorized as recreational athletes
based on the following criteria: (a) at least 3 years of experi-
ence with strength training, having completed within the
past 18months ≥3 sessions/week without interruption; (b)
a bench press one-repetition maximum (1 RM) greater
than body weight, and a full squat 1 RM 1.5 times body
weight [38]; (c) no nutritional supplements taken in the
3 months before the study outset; (d) no smoking; (e) no
disease or other impediment that could affect cycle ergo-
metry performance.
Participants in both experimental groups were volun-
teers who signed up for this study after an informative
session held 1 week before the study outset. Candidates
were first informed of the possible secondary effects of
CAFF supplementation. The study protocol fulfilled the
tenets of the Declaration of Helsinki, and was approved
by the Ethics Committee of the Universidad Alfonso X
El Sabio.
Experimental design
The study design was crossover, randomized, double-
blind, placebo-controlled. Each participant undertook
two test sessions within 48 h at the university Exercise
Physiology laboratory at the same time of day (±0.25 h).
In each session, 50% of the athletes were randomly
assigned a CAFF (6 mg/kg) or placebo (PLAC) (6 mg/kg
of sucrose) supplement.
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Upon arrival at the laboratory for each session, partici-
pants were given a supplement (CAFF or PLAC) and
after a 60 min period of rest, they completed the ques-
tionnaires profile of mood states (POMS) and subjective
vitality scale (SVS). After a standardized warm-up, the
subjects performed a Wingate test on a cycle ergometer
to assess anaerobic performance [39]. Immediately after
the test, they graded their exertion using the rate of per-
ceived exertion (RPE) scale.
Nutritional intervention
Caffeine supplements were provided in #1 non-
transparent red capsules (Guinama S.L.U, 0044634, La
Pobla de Valbona, Spain). Individual capsules were pre-
pared based on each participant’s body weight, so each
capsule supplied 6 mg/kg of either CAFF or PLAC to
each participant. Capsules were prepared following the
standard work procedure described in the Formulario
Nacional Español using a semi-automatic manual filling
machine Capsunorm 2000 (Miranda de Ebro, Spain).
The timing of supplement intake was based on the fact
that peak blood caffeine levels are reached 1 h post-
ingestion [40] and on the results of a disaggregation
quality assay described in the Real Farmacopea Española
(2005) of 13.4 min [41].
In line with previous research [42], subjects were pro-
vided with a set of guidelines to ensure each individual
ingested similar proportions of carbohydrates (60%),
lipids (30%) and proteins (10%), aiming at avoiding inter-
actions between the supplementation and any nutritional
factor. The intake of caffeine was also restricted 24 h be-
fore the study start and the subjects were provided with
a list of foodstuffs rich in caffeine (coffee, tea, mate,
energizing drinks, cola drinks, chocolate drinks and
chocolate) they should avoid.
Profile of mood states (POMS)
To assess the participants’ mood, we used the profile of
mood states (POMS) questionnaire in its original re-
duced version [43], translated into Spanish and validated
by Fuentes et al. [44]. Participants graded a set of 29
items related to mood on a Likert scale from 0 (not at
all) to 4 (extremely) in reply to the question “How do
you feel at this moment?” to assess six scales: tension,
depression, anger, vigor, fatigue and confusion.
Subjective vitality scale (SVS)
Participants’ vitality was assessed using the Spanish
version of the subjective vitality scale (SVS) [45] of
Balaguer et al. [46]. Subjects are required to indicate
their agreement with seven statements related to sub-
jective feelings of energy and vitality using a 7-point
Likert scale where 1 means “total disagreement” and
7 means “total agreement”.
Anaerobic performance
A Monark cycle ergometer (Ergomedic 828E, Vansbro,
Sweden) was used for the Wingate test. The test was
preceded by a standardized warm up as described previ-
ously [42, 47] and consisted of 30 s of cycling at max-
imum effort with a load (Kp) corresponding to 7.5% of
the subject’s body weight. The test was started from a
stop position and the first round of pedaling initiated
with the dominant leg. Participants were encouraged to
reach the maximum rpm in the shortest time possible
and try to maintain this pedaling speed until the end of
the test. Throughout the test, the athletes were moti-
vated by 5 investigators.
Power (W) was recorded during each second of the
test. The following variables were subsequently calcu-
lated: the highest W value recorded during the test or
peak power (Wpeak), the time in seconds (s) taken to
reach Wpeak (Time Wpeak), mean W for the test dur-
ation (Wmean) and minimum power (Wmin), taken as
the lowest W recorded during the last 10 s of the test.
Rating of perceived exertion (RPE)
In line with previous research [48], a 6 to 20 RPE scale
of Borg [49] was presented as soon as the Wingate test
was finished. Accordingly, participants were first asked
to report RPE regarding muscular pain felt at legs (RPE-
muscular); second, participants were asked to report RPE
only at cardiorespiratory level (RPEcardio); and finally,
participants had to declare global RPE (RPEgeneral), which
included features from both muscular and cardiorespira-
tory dimensions.
Statistical analysis
Data are presented as means ± standard deviations (SD).
The normal distribution of data was tested using the
Kolmogorov-Smirnov test, and equality of variances was
established with the Levene’s test. When an inequality of
variances was found, a non-parametric test was used, in
which case the value of the adjusted test statistic and
degrees of freedom are reported. To ensure similar
anthropometric and personal variables between elite and
trained-recreational athletes, separate Student t-tests for
independent samples (elite vs. trained-recreational) were
run for age, weight, height, and body mass index (BMI),
respectively.
To compare the effects of CAFF supplementation on
physical and psychological measures between the two
groups of athletes, separate 2 × 2 independent analyses
of variance for repeated measures (ANOVA-RM) were
applied for each variable recorded. Performance level
(elite vs. trained-recreational) was introduced as an
inter-subject factor, whereas Supplementation (CAFF vs.
PLAC) was used as an intra-subject factor. Practical sig-
nificance for pairwise comparisons was assessed by
Jodra et al. Journal of the International Society of Sports Nutrition            (2020) 17:2 Page 3 of 11
calculating Cohen’s d effect size [50]. Effect sizes (d) of
above 0.8, between 0.8 and 0.5, between 0.5 and 0.2 and
lower than 0.2 were considered as large, moderate, small,
and trivial, respectively [51]. Further, ANOVA-RM effect
sizes were calculated using partial eta squared (η2p), and <
0.25, 0.26–0.63 and > 0.63 considered small, medium
and large effect sizes respectively [52, 53]. All statistical
tests were performed using the Statistical Package for
Social Sciences (version 20.0 for Mac, SPSS™ Inc.,
Chicago, IL, USA). Significance was set at p < 0.05.
Results
No significant differences between experimental groups
(elite vs. trained- recreational) were detected in the vari-
ables age (t16 = 0.593; p = 0.561; d = 0.28); weight (t16 =
1.838; p = 0.085; d = 0.87); height (t9.41 = 1.694; p = 0.123;
d = 0.87); and BMI (t16 = 1.594; p = 0.130; d = 0.76).
Anaerobic performance
The results found for the anaerobic performance mea-
sures are summarized in Table 1. A significant effect of
the factors supplementation (F1,16 = 12.804; p = 0.003; η2p
= 0.44) and group (F1,16 = 8.915; p = 0.009; η2p = 0.36)
was observed when peak power was analyzed. Thus, par-
ticipants showed higher Wpeak values after CAFF supple-
mentation compared to placebo (11.22 ± 0.65 vs 10.7 ±
0.84W) whereas trained-recreational athletes showed a
higher Wpeak (11.31 ± 0.73) than the elite athletes
(10.52 ± 0.62). However, there was no significant inter-
action between supplementation and group (F1,16 =
0.652; p = 0.431; η2p = 0.04).
For the average power exerted by participants during
the Wingate test, we observed a significant effect of
supplementation (F1,16 = 18.099; p = 0.001; η2p = 0.531).
Participants showed a greater Wavg after CAFF
supplementation (8.75 ± 0.55) compared to placebo
(8.41 ± 0.46). No significant supplementation by group
interaction emerged (F1,16 = 1.197; p = 0.290; η2p =
0.07); nor did we observe a significant effect of group
(F1,16 = 0.820; p = 0.378; η2p = 0.05).
As for minimum power in the Wingate test, no signifi-
cant supplementation by group interaction was detected
(F1,16 = 0.680; p = 0.422; η2p = 0.04). Neither were any sig-
nificant effects observed of the factors supplementation
(F1,16 = 0.595; p = 0.452; η2p = 0.04) or group (F1,16 =
0.948; p = 0.345; η2p = 0.06).
Finally, when we examined the time it took the partici-
pants to achieve maximum power, a significant effect
emerged of supplementation (F1,16 = 21.138; p < 0.001;
η2p = 0.57). This meant that the athletes reached Wpeak
earlier after CAFF supplementation (7.56 ± 1.58) com-
pared to placebo (9.11 ± 1.53). There was no significant
supplementation by group interaction (F1,16 = 3.584; p =
0.077; η2p = 0.18) or a significant effect of group (F1,16 =
0.079; p = 0.783; η2p = 0.005).
Rating of perceived exertion (RPE)
Table 2 details the ratings of perceived exertion awarded
by the participants. A significant effect was detected for
the factor group (F1,16 = 6.507; p = 0.021; η2p = 0.29) in the
exertion perceived by the athletes in the legs (RPEmuscular)
whereby the trained-recreational athletes showed higher
RPEmuscular (18.20 ± 1.06) than the elite athletes (15.75 ±
3.17). There were no significant supplementation by group
interactions (F1,16 = 0.02; p = 0.889; η2p = 0.001), or sig-
nificant effects of supplementation (F1,16 = 0.376; p =
0.548; η2p = 0.02).
A significant effect of the factor group was found in exer-
tion perceived at the cardiorespiratory level (F1,16 = 6.829;
Table 1 Performance variables recorded in each experimental group
Elite Recreational p-values (ES)
Supplementation Group Supplementation x Group
Wmax Caffeine 10.85 ± 0.48 11.52 ± 0.62 0.003** (0.44) 0.009** (0.36) 0.431 (0.04)
Placebo 10.19 ± 0.59 11.11 ± 0.8
Wavg Caffeine 8.69 ± 0.38 8.8 ± 0.67 0.001**(0.53) 0.378 (0.07) 0.290 (0.05)
Placebo 8.25 ± 0.37 8.54 ± 0.51
Wmin Caffeine 6.49 ± 0.22 6.01 ± 1.1 0.452 (0.04) 0.345 (0.06) 0.422 (0.04)
Placebo 6.19 ± 0.56 6.02 ± 0.89
T Wmax Caffeine 8.00 ± 1.6 7.2 ± 1.55 <0.001*** (0.57) 0.783 (0.05) 0.077 (0.18)
Placebo 8.88 ± 1.64 9.3 ± 1.49
Data are provided as the mean ± standard deviation. Adjusted values for the test statistic (F) and degrees of freedom (df) are shown when inequality of variances
were found between groups
Abbreviations: ES: effect size; Wmax: maximum power; Wavg: average power; Wmin: minimum power; T Wmax: time to maximum power
**: p < 0.01; ***: p < 0.001
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p = 0.019; η2p = 0.3) in that the trained-recreational athletes
showed a larger RPEcardio (17.45 ± 1.64) than the elite ath-
letes (14.63 ± 3.12). There was no significant supplementa-
tion by group interaction (F1,16 = 0.077; p = 0.785; η2p =
0.005) nor significant effect of the factor supplementation
(F1,16 = 0.69; p = 0.419; η2p = 0.04).
No significant supplementation by group interaction
(F1,16 = 0.039; p = 0.846; η2p = 0.002) was found for the
general rate of perceived exertion (RPEgeneral). Moreover,
there was no significant effect of supplementation
(F1,16 = 3.172; p = 0.094; η2p = 0.16) or group (F1,16 =
3.524; p = 0.079; η2p = 0.18).
Psychological measures
In Table 3, we provide the results found for the psycho-
logical measures. A significant supplementation by
group interaction was noted for tension (F1,16 = 6.526;
p = 0.021; η2p = 0.29; Fig. 1a), which was accompanied by
a significant effect of the factor supplementation (F1,16 =
16.552; p = 0.001; η2p = 0.51). However, no significant ef-
fect of group was observed (F1,16 = 0.815; p = 0.380; η2p =
0.05). Our post-hoc pairwise analysis revealed signifi-
cantly greater tension levels reported by the elite athletes
after caffeine intake compared with placebo (8 ± 4.98 vs.
1.88 ± 3.56; p < 0.001; d = 1.43).
A significant effect of the factor group was noted when
depression measures were analyzed (F1,16 = 5.24; p =
0.036; η2p = 0.25). Elite athletes awarded more points to
the dimension depression (3.25 ± 0.93) than the trained-
recreational athletes (1.30 ± 2.7). No significant supple-
mentation by group interaction was observed (F1,16 =
1.474; p = 0.242; η2p = 0.08) nor a significant effect of
supplementation (F1,16 = 0.018; p = 0.894; η2p = 0.001).
For the dimension anger, there was no significant
interaction between supplementation and group (F1,16 =
1.481; p = 0.241; η2p = 0.08) or any significant effects of
supplementation (F1,16 = 0.165; p = 0.690; η2p = 0.01) or
group (F1,16 = 1.967; p = 0.180; η2p = 0.11).
When measures of vigor were analyzed, a significant
supplementation by group interaction was noted (F1,16 =
11.284; p = 0.004; η2p = 0.41; Fig. 1b), accompanied by a sig-
nificant effect of supplementation (F1,16 = 29.070; p < 0.001;
η2p = 0.64). However, no significant effect was detected of
the factor group (F1,16 = 2.706; p = 0.119; η2p = 0.14). Our
post-hoc pairwise analysis revealed significantly greater
vigor values for the elite than trained- recreational athletes
after caffeine supplementation (16,5 ± 2.62 vs. 13 ± 3.02;
p = 0.20; d = 1.24). Moreover, significantly higher vigor
scores were obtained for the elite athletes when these were
supplemented with caffeine rather than placebo (16.5 ± 2.62
vs. 12.63 ± 2.33; p < 0.001; d = 1.56). A significant effect of
supplementation was also found on self-reported fatigue
(F1,16 = 9.164; p = 0.008; η2p = 0.36). Accordingly, partici-
pants showed higher fatigue levels after supplementation
with placebo (4.89 ± 4.42) than CAFF (2.56 ± 2.77). There
was no significant supplementation by group interaction
(F1,16 = 3.299; p = 0.088; η2p = 0.17) nor significant effect of
group (F1,16 = 0.850; p = 0.370; η2p = 0.05).
For confusion levels reported by the participants, there
was no significant supplementation by group interaction
(F1,16 = 1.516; p = 0.236; η2p = 0.09), nor a significant ef-
fect of supplementation (F1,16 = 0.257; p = 0.619; η2p =
0.02) or group (F1,16 = 1.035; p = 0.324; η2p = 0.06).
As for the subjective vitality scale, a significant supple-
mentation by group interaction was detected (F1,16 =
11.028; p = 0.004; η2p = 0.41; Fig. 1c), along with a signifi-
cant effect of supplementation (F1,16 = 22.863; p < 0.001;
η2p = 0.59) but no significant effect of group (F1,16 =
0.292; p = 0.597; η2p = 0.02). Post-hoc pairwise compari-
sons revealed that elite athletes returned higher SVS
scores after caffeine supplementation compared to pla-
cebo (40.63 ± 4.78 vs. 31.75 ± 7.78; p < 0.001; d = 1.41).
Table 2 Ratings of perceived exertion recorded in each experimental group
Elite Recreational p-values (ES)
Supplementation Group Supplementation x Group
RPElegs Caffeine 15.63 ± 2.82 18.00 ± 1.15 0.548 (0.02) 0.021* (0.29) 0.889 (0.001)
Placebo 15.88 ± 3.68 18.40 ± 0.97
RPEcardio Caffeine 14.50 ± 3.62 17.20 ± 1.75 0.419 (0.04) 0.019* (0.30) 0.785 (0.05)
Placebo 14.75 ± 2.76 17.70 ± 1.57
RPEgeneral Caffeine 15.50 ± 3.66 17.70 ± 1.16 0.094 (0.16) 0.079 (0.18) 0.846 (0.002)
Placebo 16.13 ± 3.48 18.20 ± 0.92
Data are provided as the mean ± standard deviation. Adjusted values for the test statistic (F) and degrees of freedom (df) are shown when inequality of variances
were found between groups
Abbreviations: ES: effect size; RPElegs: exertion perceived at the level of the legs; RPEcardio: exertion perceived at the cardiorespiratory level; RPEgeneral: general
perceived exertion
*: p < 0.05
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Discussion
The present study was designed to compare the acute ef-
fects of CAFF supplementation on anaerobic perform-
ance, mood and perceived exertion in elite athletes and
moderately-trained recreational athletes. Our findings
indicate that the ergogenic effect of CAFF is determined
by an athlete’s performance level but only in terms of
variables related to mood state. Hence, elite athletes re-
ported significantly higher tension levels following the
intake of CAFF (+ 325%) than the intake of PLAC. Simi-
larly, CAFF supplementation led to significantly higher
measures of vigor compared to the effect of PLAC (+
31%) but only in the elite athletes. Further, vigor levels
reported after the intake of CAFF were significantly
higher (+ 27%) in the elite athletes than recreational ath-
letes. Finally, elite athletes also returned significantly
higher SVS scores after the intake of CAFF compared to
PLAC (+ 5.8%). In contrast, it emerged that the
Fig. 1 Panel a shows the scores recorded for the dimension tension. Higher tension scores were reported by elite athletes after supplementation
with caffeine compared to placebo; Panel b shows the scores recorded for the dimension vigor. Scores for vigor were significantly higher after
caffeine supplementation in the elite athletes compared to the trained-recreational athletes. Further, elite athletes returned higher vigor scores
after supplementation with caffeine compared to placebo; Panel c shows the scores recorded in the SVS. Elite athletes showed larger SVS values
after supplementation with caffeine versus placebo. a: significant differences were detected in elite athletes when caffeine was compared with
placebo. b: significant differences after caffeine supplementation were detected in elite athletes versus trained-recreational athletes
Table 3 Psychological measures recorded in each experimental group
Elite Recreational p-values (ES)
Supplementation Group Supplementation x Group
Tension Caffeine 8.00 ± 4.99† 4.30 ± 3.77 0.001** (0.51) 0.380 (0.05) 0.021* (0.29)
Placebo 1.88 ± 3.56 2.90 ± 2.18
Depression Caffeine 3.63 ± 0.74 1.00 ± 1.25 0.894 (0.001) 0.036* (0.25) 0.242 (0.008)
Placebo 2.88 ± 0.99 1.60 ± 3.69
Anger Caffeine 0.38 ± 1.06 2.40 ± 3.10 0.690 (0.01) 0.180 (0.08) 0.241 (0.11)
Placebo 0.88 ± 1.81 1.40 ± 2.46
Vigor Caffeine 16.50 ± 2.62†# 13.00 ± 3.02 < 0.001*** (0.64) 0.119 (0.14) 0.004** (0.41)
Placebo 12.62 ± 2.33 12.10 ± 2.85
Fatigue Caffeine 2.50 ± 3.50 2.60 ± 2.22 0.008** (0.36) 0.370 (0.05) 0.088 (0.17)
Placebo 6.50 ± 4.54 3.60 ± 4.09
Confusion Caffeine 14.63 ± 3.54 12.20 ± 3.99 0.619 (0.02) 0.324 (0.06) 0.236 (0.09)
Placebo 14.13 ± 4.36 13.40 ± 2.22
SVS Caffeine 40.63 ± 4.78† 38.40 ± 5.44 < 0.001*** (0.59) 0.597 (0.02) 0.004** (0.41)
Placebo 31.75 ± 7.78 36.80 ± 5.71
Data are provided as the mean ± standard deviation. Adjusted values for the test statistic (F) and degrees of freedom (df) are shown when inequality of variances
were found between groups
Abbreviations: SVS: subjective vitality scale; ES: effect size
*: p < 0.05; **: p < 0.01; ***: p < 0.001; †: significant differences for caffeine versus placebo at the group level; #: significant differences detected between elite and
recreational athletes at the supplementation level
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ergogenic effect of CAFF on measures of anaerobic per-
formance were independent of the athletes’ training
level.
In line with prior work, studies have shown that CAFF
supplementation produces an increase in peak and aver-
age power and that this effect is not conditioned by the
performance level of the athlete [19, 54, 55]. Consist-
ently, we observed here that CAFF intake led to a
shorter time needed to reach peak power in both experi-
mental groups (− 9.9% in elite and 22.5% in trained-
recreational athletes). These data suggest that an ath-
lete’s training level does not modify the ergogenic effect
exerted by CAFF supplementation on anaerobic per-
formance (i.e., peak and average power). Our results are
line with the ergogenic effect of CAFF observed both in
elite athletes [13, 35, 36] and in recreational athletes
[37], and also with the improved physical performance
noted after the intake of CAFF in trained and untrained
athletes [34]. In contrast, Collomp et al. reported an er-
gogenic CAFF effect in an anaerobic capacity field test
(100 m freestyle swimming) in trained swimmers but not
in untrained swimmers [33]. If we consider evidence
suggesting that the amount of supplemented CAFF de-
termines its potential ergogenic effect [56–58], it seems
reasonable that this variable could explain the disparate
results obtained in our study and the report by Collomp
et al. [33]. While the dose of CAFF in the present study
was personalized (6 mg/kg), Collomp et al. used a stand-
ard dose of 250 mg (~ 4.3 mg/kg) [33]. Moreover, as it
has been established that CAFF supplementation pro-
duces a greater effect on movement velocity as the dose
is increased and, especially, as the load is increased [59],
the greater amount of CAFF used here could explain our
different results to those of Collomp et al. [33].
Another explanation for the different results obtained
by Collomp et al. could be the type of physical test used
[33]. Thus, while we used a standard test to assess anaer-
obic capacity (Wingate test), Collomp et al. employed a
test that was specific for the athletes tested (i.e., 100 m
freestyle) [33]. This could explain why our trained-
recreational athletes developed more peak power than
the elite athletes, although other studies have detected
no differences in physical performance between
different-level athletes [60, 61] or between boxers and
physically inactive individuals [62]. Notwithstanding,
elite boxers were found to show improved anaerobic
performance compared to amateur boxers in an arm
cycle ergometry Wingate test [63, 64]. This could sug-
gest that the higher peak power value recorded in our
recreational athletes reflected the greater adaptation of
these athletes to maximal efforts executed with the legs,
regardless of the specificity of the anaerobic test per-
formed according to the given sports modality. In future
work, the ergogenic effect of CAFF should be examined
in different level athletes (elite vs. trained-recreational)
who practice the same sports activity in physical per-
formance tests specific to the physiological and bio-
mechanical needs of that sport.
The effects of caffeine on anaerobic performance may
be explained by both peripheral and central mechanisms.
At the peripheral level, the effects of CAFF supplemen-
tation, such as enhanced neuromuscular recruitment
[14, 15] and increased bioavailability of calcium in the
myoplasm [16], could explain the positive effect on
power production by the muscle and thus explain the er-
gogenic effects observed in the Wingate test. Centrally,
CAFF is an adenosine antagonist, increasing neurotrans-
mitter synthesis [11, 12] and nervous system stimulation
[65]. How these effects impact RPE and physical per-
formance are still being explored [66]. Studies have
shown that CAFF doses of 3–6 mg/kg give rise to im-
proved performance and reduced RPE in sets of resist-
ance exercise with submaximal loads [67], and physical
condition tests in basketball players [68]. In Wingate
tests, improved ergometry performance in the arms ac-
companied by a decline in RPE has been observed [69],
as well as improved performance in the legs both in
moderately-trained subjects [70] and trained judokas
[71, 72]. We could not confirm any beneficial effects of
CAFF on RPE here. However, the improved Wavg levels
observed associated with a similar RPE, suggest that
CAFF supplementation exerts its positive effects by
allowing a greater workload for a given RPE [73, 74],
since it would be reasonable to expect lower RPE values
at CAFF condition (compared to PLAC) if similar per-
formance were registered for both experimental condi-
tions [75]. Accordingly, CAFF seems to modify the
relationship between workload and RPE, reducing RPE
for a given load [76]. Therefore, some of the ergogenic
effects of CAFF could take place via a diminished sensa-
tion of fatigue induced by exercise [77].
As adenosine increases pain and tiredness perception
while it diminishes arousal [10], CAFF supplementation,
through its effects on adenosine, could have a positive
effect on a person’s mood state [25, 78]. Some authors
propose that an increased mood state via augmented
tension, reflects an optimal emotional state to approach
a physical task [48]. This determines that small increases
in tension levels before exercise could lead to improved
performance [79]. Our results indicate that CAFF sup-
plementation has an effect in high-performance athletes.
This is consistent with studies in which improved per-
formance was accompanied by increases in tension and
vigor and a reduction in fatigue in elite judo athletes [71,
72, 80]. In an attempt to explain such enhanced tension
levels only in elite athletes, Lane et al. [81] and Lane and
Jarret [82] argued that elite athletes are accustomed to
high levels of tension and vigor, and that this leads to
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adaptation to variations met in situations of high phys-
ical demands to optimize the state of approaching a task
[26, 30]. This situation is uncommon in recreational ath-
letes. In a study examining fatigue perception, Paton
et al. measured sprints in trained cyclists who trained
under the effects of caffeine or placebo [83]. The authors
noted that acute CAFF intake significantly reduced the
feeling of fatigue when executing a repeated high-
intensity exercise in elite cyclists, coinciding with the
findings of studies conducted in moderately-trained [84]
and recreational athletes [27]. In our study, the sensation
of fatigue diminished significantly in both groups of
athletes when taking caffeine as a supplement before
conducting a maximum intensity task. This evidence of
the effects of CAFF in increasing tension and vigor, and
diminishing the sensation of fatigue in the case of elite
boxers allows for adaptation to an optimal state for
facing maximum intensity explosive actions.
In the depression dimension of the POMS question-
naire, the professional boxers scored higher than the rec-
reational athletes. While several studies indicate that
practicing sports improves mood in terms of improving
depression [85, 86], two literature reviews [87]. reported
that athletes of sports modalities possibly causing con-
cussion (e.g., boxing), showed high prevalence of depres-
sion symptoms. Thus, repeated concussion episodes
produced after a blow transmitting an inertial force to
the brain can give rise to depressive symptoms [88]. This
is attributable to a strong correlation observed between
athletes with a history of concussion and abnormalities
in frontal lobe alpha waves and symptoms of depression
[89]. Studies have identified a substantial increase (~
20%) in depression symptoms in athletes who have suf-
fered concussion [90, 91]. Further, athletes of sports with
a risk of concussion such as American football, rugby or
boxing are 2 to 3 times more likely to suffer from de-
pression than the general population [92–94]. This
means it could be that the differences detected here be-
tween groups were linked to the sports modality of the
high-performance athletes (i.e., boxing). Therefore, there
is need to evaluate potential associations between con-
cussion and depression symptoms in future studies, in
which different athletes’ cohorts should be recruited.
This would allow researchers to analyze potential under-
lying mechanisms for depression, in addition to broaden
our knowledge regarding concussion-related mental dis-
orders (i.e. anxiety), which have been previously studied
in retired athletes [95, 96].
Limitations of the study
Individual caffeine tolerance has been previously associ-
ated with decreased ergogenic effect of caffeine supple-
mentation, resulting from an increased activity of the
adenosine receptors, along with a decreased β-adrenergic
activity [25]. Unfortunately, it was not possible for us to
control for individual’s caffeine tolerance on this study,
since participant’s average caffeine intake was not re-
corded. Therefore, habituation to caffeine may have been
a potential confound variable on our study, and it should
be controlled in future research aiming at comparing the
ergogenic effect of caffeine between different populations.
Although a set of nutritional guidelines was given to
each participant, in order to ensure similar proportions
of ingested macronutrients, individual dietary compli-
ance was not assessed. Thus, there is need for control of
this variable in future research, in order to fully can-
celled potential interactions between supplementation
and nutritional factors.
Finally, recruitment criteria associated with strength
parameters (i.e. bench press 1RM greater than body
weight, and 1RM 1.5 times body weight in full squat)
were only applied for the recreational group. Thus, it
cannot be fully discarded that between-group differences
found for peak and average power resulted from poten-
tial strength differences between experimental groups. It
is recommended that future research controls for this
potential confound variable.
Conclusions
Supplementation with 6 mg/kg of CAFF had an ergo-
genic effect on anaerobic performance, improving aver-
age power, peak power and the time needed to reach
peak power in elite and in trained-recreational athletes.
These improvements took place without a concomitant
increase in RPE. Further, CAFF supplementation led to
considerable improvements in factors contributing to
mood state such as tension, vigor and vitality perception,
but only in the elite athletes. In order to be able to
generalize our conclusions to different athletes’ popula-
tions, future research is needed aiming at comparing caf-
feine’s ergogenic effect on recreationally-trained athletes
and elite athletes from different sport modalities.
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